A detailed history of Wells Fargo & Company transactions in Opti Nose, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 465 shares of OPTN stock, worth $311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
465
Previous 22,078 97.89%
Holding current value
$311
Previous $32,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.82 - $1.44 $17,722 - $31,122
-21,613 Reduced 97.89%
465 $0
Q1 2024

May 10, 2024

BUY
$1.17 - $1.94 $3,417 - $5,666
2,921 Added 15.25%
22,078 $32,000
Q4 2023

Feb 09, 2024

BUY
$1.02 - $1.47 $4,388 - $6,323
4,302 Added 28.96%
19,157 $24,000
Q3 2023

Nov 13, 2023

SELL
$0.93 - $1.38 $14,760 - $21,903
-15,872 Reduced 51.65%
14,855 $18,000
Q2 2023

Aug 15, 2023

BUY
$1.11 - $2.05 $33,222 - $61,356
29,930 Added 3755.33%
30,727 $37,000
Q1 2023

May 12, 2023

BUY
$1.63 - $2.02 $326 - $404
200 Added 33.5%
797 $1,000
Q4 2022

Feb 13, 2023

SELL
$1.68 - $3.7 $29,060 - $64,002
-17,298 Reduced 96.66%
597 $1,000
Q3 2022

Nov 14, 2022

BUY
$3.43 - $4.01 $59,040 - $69,024
17,213 Added 2523.9%
17,895 $65,000
Q2 2022

Aug 12, 2022

BUY
$1.76 - $3.82 $760 - $1,650
432 Added 172.8%
682 $3,000
Q4 2021

Feb 14, 2022

SELL
$1.55 - $3.1 $333 - $666
-215 Reduced 46.24%
250 $0
Q3 2021

Nov 15, 2021

SELL
$2.35 - $3.16 $39 - $53
-17 Reduced 3.53%
465 $2,000
Q2 2021

Aug 16, 2021

SELL
$2.91 - $3.83 $31,308 - $41,206
-10,759 Reduced 95.71%
482 $2,000
Q1 2021

May 13, 2021

SELL
$3.47 - $4.75 $199,826 - $273,538
-57,587 Reduced 83.67%
11,241 $41,000
Q4 2020

Feb 09, 2021

BUY
$3.2 - $4.98 $58,230 - $90,621
18,197 Added 35.94%
68,828 $286,000
Q3 2020

Nov 05, 2020

SELL
$3.69 - $7.09 $45,449 - $87,327
-12,317 Reduced 19.57%
50,631 $197,000
Q2 2020

Aug 13, 2020

BUY
$3.58 - $7.44 $59,549 - $123,756
16,634 Added 35.92%
62,948 $469,000
Q1 2020

May 14, 2020

BUY
$3.49 - $9.2 $161,635 - $426,088
46,314 New
46,314 $208,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $55.8M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.